HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kenneth M Verburg Selected Research

tanezumab

4/2022Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase III safety study.
3/2022Neurological safety of subcutaneous tanezumab versus NSAID in patients with osteoarthritis.
1/2022Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study.
1/2022Response to: 'Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues' by Riddle and Perera.
12/2021Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis.
1/2021Long-Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial.
1/2021Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?
1/2021Postoperative Outcome of Patients Who Underwent Total Joint Replacement During the Tanezumab Phase 3 Osteoarthritis Development Program: A 24-Week Observational Study.
1/2020Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period.
1/2020Tanezumab for chronic low back pain: a randomized, double-blind, placebo- and active-controlled, phase 3 study of efficacy and safety.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kenneth M Verburg Research Topics

Disease

26Pain (Aches)
01/2022 - 01/2002
15Osteoarthritis
03/2022 - 04/2002
8Hip Osteoarthritis (Coxarthrosis)
03/2022 - 11/2014
6Postoperative Pain
09/2006 - 01/2002
5Low Back Pain (Lumbago)
04/2022 - 01/2013
4Arthralgia (Joint Pain)
01/2021 - 01/2013
3Chronic Pain
02/2016 - 01/2013
3Myocardial Infarction
01/2007 - 02/2002
3Stroke (Strokes)
01/2007 - 02/2002
3Arthritis (Polyarthritis)
10/2002 - 02/2002
2Peripheral Nervous System Diseases (PNS Diseases)
03/2022 - 01/2015
2Knee Osteoarthritis
01/2022 - 01/2021
2Osteonecrosis (Kienbock's Disease)
02/2016 - 09/2014
2Paresthesia (Dysesthesia)
11/2014 - 01/2013
2Edema (Dropsy)
11/2014 - 02/2002
2Acute Pain
05/2002 - 01/2002
2Hypertension (High Blood Pressure)
04/2002 - 02/2002
1Mononeuropathies (Mononeuritis Multiplex)
03/2022
1Radiculopathy (Radiculopathy, Cervical)
03/2022
1Polyneuropathies (Polyneuropathy)
03/2022
1Stress Fractures (Stress Fracture)
02/2016
1Cancer Pain
02/2016
1Neoplasm Metastasis (Metastasis)
09/2015
1Neuralgia (Stump Neuralgia)
01/2015
1Postherpetic Neuralgia
01/2015
1Hyperesthesia
11/2014
1Hypesthesia (Numbness)
11/2014
1Headache (Headaches)
01/2013
1Fever (Fevers)
08/2008
1Vomiting
08/2008
1Rheumatoid Arthritis
02/2006
1Heart Arrest (Cardiac Arrest)
03/2005
1Pulmonary Embolism
03/2005
1Tendinopathy (Tendonitis)
08/2004
1Bursitis (Adhesive Capsulitis)
08/2004
1Peptic Ulcer (Peptic Ulcers)
10/2002
1Dysmenorrhea (Menstrual Pain)
08/2002
1Body Weight (Weight, Body)
04/2002
1Essential Hypertension
04/2002
1Inflammation (Inflammations)
03/2002
1Heart Failure
02/2002

Drug/Important Bio-Agent (IBA)

20tanezumabIBA
04/2022 - 01/2013
11valdecoxib (Bextra)FDA Link
09/2006 - 01/2002
10Analgesics (Analgesic Drugs)IBA
01/2021 - 01/2002
8Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
03/2022 - 02/2002
8Nerve Growth Factor (NGF)IBA
01/2022 - 01/2013
6Prostaglandins AIBA
01/2022 - 01/2013
6Opioid Analgesics (Opioids)IBA
09/2015 - 01/2002
5Celecoxib (Celebrex)FDA Link
04/2022 - 02/2002
5Naproxen (Naprosyn)FDA LinkGeneric
11/2014 - 08/2002
5parecoxibIBA
11/2008 - 03/2005
4Monoclonal AntibodiesIBA
02/2016 - 01/2013
4Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
10/2002 - 01/2002
3Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2007 - 04/2002
3Morphine (MS Contin)FDA LinkGeneric
03/2006 - 01/2002
1NAD (NADH)IBA
01/2015
1ProdrugsIBA
03/2005
1Ibuprofen (Motrin)FDA LinkGeneric
10/2002
1Diclofenac (SR 38)FDA LinkGeneric
10/2002
1oxycodone-acetaminophen (Percocet)FDA LinkGeneric
05/2002
1PotassiumIBA
04/2002
1CreatinineIBA
04/2002
1Lisinopril (Prinivil)FDA LinkGeneric
04/2002
1Antihypertensive Agents (Antihypertensives)IBA
04/2002
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
04/2002
1EnzymesIBA
03/2002
1rofecoxib (Vioxx)FDA Link
03/2002

Therapy/Procedure

7Analgesia
09/2015 - 03/2002
3Replacement Arthroplasty
01/2021 - 09/2014
3Oral Surgery (Maxillofacial Surgery)
09/2002 - 03/2002
1Therapeutics
01/2021
1Duration of Therapy
01/2015
1Hip Replacement Arthroplasty (Total Hip Replacement)
08/2008
1Gynecologic Surgical Procedures (Gynecologic Surgery)
09/2007
1Laparotomy
09/2007
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
03/2005
1Combined Modality Therapy
01/2002
1Orthopedic Procedures
01/2002
1Arthroplasty
01/2002